Latest News - PKO Bank Polski
Top Corporates Hub
PKO Bank Polski
Agilent Technologies (A) Expands Tumor Profiling With New Pan Heme Research Panel
12.11.2026 06:09
Agilent Technologies (NYSE:A) introduced the SureSelect Cancer Research Pan Heme panel for tumor profiling in hematologic malignancies. The new assay is co-developed with hematology experts to support comprehensive genomic profiling in blood cancer research workflows. SureSelect Cancer Research Pan Heme integrates advanced genomic technologies and streamlined processes for precision oncology investigations. The launch of SureSelect Cancer Research Pan Heme matters, but investors need to...
How Much Passive Income $50,000 Generates in These 4 High Yield REITs
11.11.2026 15:32
Four REITs pay retirees on a schedule, but one of them survived a dividend collapse and another leans on theater tenants. Before chasing yield, see which payouts have real cushion and which risks could quietly erode the checks.
Is Illumina Stock Worth The Wait?
11.11.2026 15:29
For questions about this article or underlying research, email help@trefis.com.
Mass Spectrometry - Global Strategic Business Report 2026-2032 Featuring Thermo Fisher, Agilent, Bruker, Shimadzu, Waters and More
11.11.2026 14:42
Capitalize on demand for high-sensitivity MS, hybrid LC-MS/GC-MS platforms, and software-led services across biopharma, diagnostics, food safety and environmental testingDublin, Nov. 11, 2026 (GLOBE NEWSWIRE) -- "Mass Spectrometry - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global mass spectrometry market was valued at US$2.3 billion in 2025 and is projected to reach US$3.3 billion by 2032, expanding at a compound annual growth rate (CAGR) of 5.1%
RNA Analysis / Transcriptomics - Global Strategic Business Report: Capitalize on 13.4% CAGR to $19B by 2030 as Agilent, Beckman Coulter, bioMerieux, BGI Genomics, and 10X Genomics Accelerate
11.11.2026 14:22
Target reagents, personalized medicine, single-cell sequencing and diagnostics; leverage tariff and regional insights to optimize sourcing, investment and revenue opportunities.Dublin, Nov. 11, 2026 (GLOBE NEWSWIRE) -- "RNA Analysis / Transcriptomics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global RNA analysis / transcriptomics market was valued at US$8.9 billion in 2024 and is projected to reach US$19 billion by 2030, expanding at a compound a
Single-Cell Analysis - Global Strategic Business Report 2026: Capitalize on 20.4% CAGR as Illumina, Thermo Fisher Scientific, Bio-Rad and Agilent Battle for Shares in the $26.1 Billion Market by 2032
11.11.2026 14:18
Dublin, Nov. 11, 2026 (GLOBE NEWSWIRE) -- "Single-Cell Analysis - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global single-cell analysis market was valued at US$7.1 billion in 2025 and is projected to reach US$26.1 billion by 2032, expanding at a compound annual growth rate (CAGR) of 20.4%. Growth is being supported by increasing demand for precision medicine, targeted therapies, biomarker discovery and advanced cellular research across pharma
Molecular Cytogenetics - Global Strategic Business Report: Capitalize on 8.8% CAGR to US$3.5 Billion by 2030; Outmaneuver Abbott, Agilent, Bio-Rad, Illumina and Roche Amid Tariff Shifts
11.11.2026 14:13
Capitalize on personalized medicine, advanced genetic testing and cancer diagnostics with tariff-aware sourcing, regional analysis and competitive insights.Dublin, Nov. 11, 2026 (GLOBE NEWSWIRE) -- "Molecular Cytogenetics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global molecular cytogenetics market was valued at US$2.1 billion in 2024 and is projected to reach US$3.5 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.8% fro
Genetic Testing - Global Strategic Business Report: Secure Share of a US$26.4 Billion Market by 2030 as Agilent Technologies, Asuragen, Biocartis, and Agena Bioscience Accelerate
11.11.2026 14:11
Capitalize on NGS, AI-enabled bioinformatics, direct-to-consumer testing and personalized medicine, guided by tariff, regional and competitive insights.Dublin, Nov. 11, 2026 (GLOBE NEWSWIRE) -- "Genetic Testing - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global Genetic Testing Market to Reach US$26.4 Billion by 2030 as Genomic Innovation Accelerates The global genetic testing market was valued at US$15 billion in 2024 and is projected to reach US$26.4
Realty Income Doubled Its Loan Income to $105 Million. Is the Monthly Dividend Landlord Becoming a Lender?
11.11.2026 07:06
Key TakeawaysRealty Income raised its 2026 AFFO outlook to $4. 45 to $4.
W. P. Carey: 140% Coverage Buffer, Organic Growth, Solid 5% Yield
11.11.2026 06:51
The bull case for W.P. Carey: at 12.3x 2026 AFFO, shares could gain 21% if growth and acquisitions lift the multiple to ~15x.
Coca-Cola Is Up 5% Since Reporting Earnings. Here's Why It's Still an All-Star Stock to Buy and Hold.
11.11.2026 03:35
Coca-Cola isn't cheap, but history suggests that a buy-and-hold approach will pay off over the long term.
Realty Income Just Raised Its Dividend Hours After the 10-Year Treasury Hit 5%. A Widow With $300,000 in the Stock Now Gets $1,370 a Month. Here’s How Safe the Check Is
11.11.2026 03:27
Realty Income raised its monthly dividend to $0.274 a share on Tuesday, hours after the 10-year Treasury touched 5%. For a 72-year-old widow with 5,000 shares, that is $1,370 a month. Here is how well the cash covers it, what a 5% Treasury does to the share price, and why the check costs her half as much tax in a brokerage account as it would from her IRA.
Treasuries Now Offer 2.66% Above Inflation. Are Dividend Stocks in Trouble?
10.11.2026 19:17
Real yields hit a level that crushed income stocks once before, and one dividend name is already repeating the old script. Which holdings sat out the damage this time, and what single number could turn the tide again?
Why Is WPP (LSE:WPP) Challenging Agency Pitch Rules In Public?
10.11.2026 17:14
WPP (LSE:WPP) and rival Publicis have entered a rare public dispute over how major advertising accounts are awarded. The clash focuses on so called pitchless wins for global clients such as Coca Cola and PepsiCo and the fairness of such processes. Both groups are using the row to question each other's approach to client acquisition, technology use and internal operating models. The escalation of the WPP and Publicis pitch dispute only tells part of the story for investors watching the...
I Bonds Pay 5.51%. Why Retirees Might Still Prefer Dividend Stocks
10.11.2026 15:47
A Treasury-backed bond out-yields Coca-Cola and Qualcomm by a wide margin, yet retirees keep buying dividend stocks. Between lockups, state taxes, and a missing paycheck, the real math may surprise you.
Telynet's ReDI Connects Field Sales and Digital Ordering in New York's Coca-Cola System
10.11.2026 13:00
A New York store owner can keep working with a familiar sales representative while ordering from a phone at 11 p.m. on Sunday. The customer, pricing, promotions, and bottler remain the same. Rather than waiting for the next visit, the owner can replenish low stock without changing the established commercial relationship. Telynet's ReDI platform already enables this flexibility in one of America's most competitive markets.
Forget Share Price Hype: This Monthly Dividend Stock Fits Warren Buffett’s 10-Year Test
09.11.2026 18:27
We just published our list of the 10 Stocks I Am Retiring On, and Realty Income Corporation (NYSE:O) ranked 8th on the list. A retirement portfolio needs businesses that can keep rewarding shareholders long after the current market narrative fades. Dividends show how important those quieter sources of return can be: according to S&P Dow […]
$400,000 in Dividend Stocks: How a Roth IRA Could Save You $3,780 a Year
09.11.2026 18:17
The highest-yielding stock in this six-stock dividend portfolio is not the one costing you the most at tax time. Find out which holding triggers the biggest bill, and why where you park it matters more than what it pays.
3 Monthly Dividend Stocks That Could Help Pay Your Retirement Bills
09.11.2026 17:47
Your bills show up every month, but most dividend checks only arrive four times a year. Three monthly payers promise to close that gap, though one of them carries a hidden catch that could shrink part of the paycheck.
Structural Biology and Molecular Modeling Techniques - Global Strategic Business Report 2026: Capitalize on the $18 Billion 2032 Market with Agilent, Bruker Daltonics, Dassault Systemes, and Illumina
09.11.2026 15:41
Dublin, Nov. 09, 2026 (GLOBE NEWSWIRE) -- "Structural Biology and Molecular Modeling Techniques - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global structural biology and molecular modeling techniques market was valued at US$5.9 billion in 2025 and is projected to reach US$18 billion by 2032, expanding at a compound annual growth rate (CAGR) of 17.3%. Market growth is being supported by rising demand for targeted drug discovery, precision medicine,